We’ve all seen it play out right in front of us – as the world briskly switched to an almost exclusively digital landscape, personalized interaction and support services for patients followed in suit. The result? A drastic change in patients’ and clinicians’ expectations of outreach and engagement.

There’s no choice but to get quality assets into their hands fast. And one key bottleneck – getting materials through medical, legal and regulatory (MLR) review processes - has to adapt. From leveraging advanced analytics and technology to streamline process, to building agile capability in marketing materials development, emerging innovation in promotional material review is seeing leading companies excel in 2020’s ‘new normal’.

This webinar will bring together experts in digital engagement, marketing regulatory guidance and patient experience to discuss how you can nimbly convert promising ideas into utilized solutions:

  • Gain a deep and nuanced understanding of the industry-wide impact of COVID-19 on patient engagement and marketing materials development
  • Enable streamlined workstreams and overcome process bottlenecks to facilitate faster, high quality reviews
  • Uncover how advanced analytics, AI and ML can optimize your processes around MLR review – and get to market sooner
  • Establish critical KPIs that elevate internal process, such as decreasing resources needed and increased consistency in materials

Panelists include:

Headshot
Logo

Jennifer Klein Head, Strategic Scaling, Measurement & MLR Planning AstraZeneca

Headshot
Logo

Susan Garfield DrPH Commercial Leader, US Health Sciences & Wellness EY

Headshot
Logo

Chetak Buaria Global Head of Customer Engagement & Channel Evolution Merck KGaA, Darmstadt, Germany

Moderator:

Headshot
Logo

Izzy Gladstone VP Marketing Reuters Events